Capital Group Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
27,499
+3,647
| +15% | +$1.62M | 2.18% | 7 |
|
|
2025
Q1 | $11.6M | Buy |
23,852
+271
| +1% | +$131K | 2.36% | 8 |
|
|
2024
Q4 | $9.5M | Buy |
23,581
+2,435
| +12% | +$981K | 1.8% | 10 |
|
|
2024
Q3 | $9.83M | Sell |
21,146
-227
| -1% | -$106K | 1.98% | 8 |
|
|
2024
Q2 | $10M | Buy |
21,373
+178
| +0.8% | +$83.4K | 2.16% | 7 |
|
|
2024
Q1 | $8.86M | Buy |
21,195
+3,264
| +18% | +$1.36M | 1.59% | 11 |
|
|
2023
Q4 | $7.3M | Buy |
17,931
+1,008
| +6% | +$410K | 0.77% | 40 |
|
|
2023
Q3 | $5.88M | Buy |
16,923
+112
| +0.7% | +$38.9K | 0.38% | 82 |
|
|
2023
Q2 | $5.92M | Buy |
16,811
+2,234
| +15% | +$786K | 0.29% | 82 |
|
|
2023
Q1 | $4.59M | Sell |
14,577
-2,080
| -12% | -$655K | 0.25% | 90 |
|
|
2022
Q4 | $4.81M | Buy |
+16,657
| New | +$4.81M | 0.19% | 95 |
|